Afinitor ( DrugBank: - )

3 diseases

ID	Disease name (Link within this page)	Number of trials
34	Neurofibromatosis	2
89	Lymphangioleiomyomatosis	3
158	Tuberous sclerosis	5

34. Neurofibromatosis

Clinical trials : 133 / Drugs : 186 - (DrugBank : 67) / Drug target genes : 79 - Drug target pathways : 190

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01419639 (ClinicalTrials.gov)	October 2011	17/8/2011	Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2	Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2	Neurofibromatosis Type II	Drug: Everolimus (RAD001) , Afinitor®	New York University School of Medicine	Novartis Pharmaceuticals;The Children's Tumor Foundation	Completed	3 Years	N/A	All	10	Phase 2	United States
2	EUCTR2011-002228-42-FR (EUCTR)		29/08/2011	N/A	N/A - AFINF2	MedDRA version: 14.0;Level: PT;Classification code 10029268;Term: Neurofibromatosis;System Organ Cl ...	Trade Name: Afinitor Product Name: Afinitor INN or Proposed INN: Evérolimus Other descriptive name: RAD ...	ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)	NULL	Not Recruiting			Female: yes Male: yes		Phase 2	France

First Previous1Next Last

89. Lymphangioleiomyomatosis

Clinical trials : 38 / Drugs : 38 - (DrugBank : 15) / Drug target genes : 18 - Drug target pathways : 118

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2010-019825-32-FR (EUCTR)	29/06/2010	28/05/2010	An exploratory, open label, non-randomized, within-patient multiple dose-escalation safety, tolerabi ...	An exploratory, open label, non-randomized, within-patient multiple dose-escalation safety, tolerabi ...	Lymphangioleiomyomatosis MedDRA version: 12.1;Level: LLT;Classification code 10049459;Term: Lymphang ...	Product Code: RAD001 INN or Proposed INN: everolimus Trade Name: Afinitor Product Code: RAD001 INN or Pr ...	Novartis Pharma Service AG	NULL	Not Recruiting	Female: yes Male: no	24		France;Italy
2	EUCTR2008-002113-48-GB (EUCTR)	06/08/2009	22/05/2009	Efficacy and Safety of RAD001 in patients aged 18 and over with Angiomyolipoma associated with eithe ...	A randomized double-blind, placebo-controlled study of RAD001 in the treatment of Angiomyolipoma in ...	Angiomyolipoma in patients with either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomy ...	Trade Name: Afinitor5mg Tablets Product Name: RAD001 Product Code: RAD001 INN or Proposed INN: Everolim ...	Novartis Pharma Services AG	NULL	Not Recruiting	Female: yes Male: yes	118	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	France;United States;Canada;Spain;Russian Federation;Netherlands;Germany;Italy;Japan;United Kingdom
3	EUCTR2008-002113-48-DE (EUCTR)		12/02/2009	Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Eithe ...	A randomized double-blind, placebo-controlled study of RAD001 in the treatment of Angiomyolipoma in ...	Angiomyolipoma in patients with either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomy ...	Trade Name: Afinitor Product Name: RAD001 5mg Product Code: RAD001 INN or Proposed INN: EVEROLIMUS	Novartis Pharma Services AG	NULL	Not Recruiting	Female: yes Male: yes	118	Phase 3	France;United States;Canada;Spain;Russian Federation;Netherlands;Germany;Italy;United Kingdom;Japan

First Previous1Next Last

158. Tuberous sclerosis

Clinical trials : 112 / Drugs : 71 - (DrugBank : 19) / Drug target genes : 35 - Drug target pathways : 118

diseases per page:

Showing 1 to 5 of 5 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03525834 (ClinicalTrials.gov)	November 9, 2018	3/5/2018	Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associat ...	Phase IV, Single Arm Study of Safety and Efficacy of Everolimus in Chinese Adults With Tuberous Scle ...	Renal Angiomyolipoma	Drug: Everolimus	Novartis Pharmaceuticals	NULL	Completed	18 Years	N/A	All	40	Phase 4	China
2	EUCTR2011-004854-25-GB (EUCTR)	10/01/2012	22/11/2011	TRON: A trial to examine the effectiveness of the study drug (Everolimus) in the treatment of cognit ...	TRON: A randomised, double blind, placebo-controlled study of RAD001 (Everolimus) in the treatment o ...	Tuberous Sclerosis Complex (TSC) MedDRA version: 14.0;Level: PT;Classification code 10002649;Term: A ...	Trade Name: Afinitor Product Name: Everolimus INN or Proposed INN: Everolimus Other descriptive name: R ...	Cardiff University	NULL	Not Recruiting			Female: yes Male: yes	48	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	United Kingdom
3	EUCTR2008-002113-48-GB (EUCTR)	06/08/2009	22/05/2009	Efficacy and Safety of RAD001 in patients aged 18 and over with Angiomyolipoma associated with eithe ...	A randomized double-blind, placebo-controlled study of RAD001 in the treatment of Angiomyolipoma in ...	Angiomyolipoma in patients with either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomy ...	Trade Name: Afinitor5mg Tablets Product Name: RAD001 Product Code: RAD001 INN or Proposed INN: Everolim ...	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	118	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	France;United States;Canada;Spain;Russian Federation;Netherlands;Germany;Italy;Japan;United Kingdom
4	EUCTR2010-022583-13-FR (EUCTR)		01/03/2011	An open-label, multi-center, expanded access study of RAD001 in patients with subependymal giant cel ...	An open-label, multi-center, expanded access study of RAD001 in patients with subependymal giant cel ...	The study will evaluate the safety of RAD001 in patients with subependymal giant cell astrocytomas ( ...	Product Name: everolimus Product Code: RAD001 INN or Proposed INN: everolimus Other descriptive name: E ...	Novartis Pharma Services AG	NULL	NA			Female: yes Male: yes	250	Phase 3	France;Czech Republic;Hungary;Greece;Belgium;Spain;Germany;Italy
5	EUCTR2008-002113-48-DE (EUCTR)		12/02/2009	Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Eithe ...	A randomized double-blind, placebo-controlled study of RAD001 in the treatment of Angiomyolipoma in ...	Angiomyolipoma in patients with either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomy ...	Trade Name: Afinitor Product Name: RAD001 5mg Product Code: RAD001 INN or Proposed INN: EVEROLIMUS	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	118	Phase 3	France;United States;Canada;Spain;Russian Federation;Netherlands;Germany;Italy;United Kingdom;Japan

First Previous1Next Last